Skip to content
healthcare.dev

ORFADIN

NDC 66658-204, nitisinone, suspension, from Swedish Orphan Biovitrum AB (publ).

Product NDC
66658-204
Status
Listed
Labeler
Swedish Orphan Biovitrum AB (publ)
Dosage form
SUSPENSION
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA206356
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/66658-204 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • NITISINONE4 mg/mL

Pharmacologic classes

4-Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor [EPC]; Cytochrome P450 2C9 Inhibitors [MoA]; Cytochrome P450 2E1 Inducers [MoA]; Hydroxyphenylpyruvate Dioxygenase Inhibitors [MoA]; Organic Anion Transporter 1 Inhibitors [MoA]; Organic Anion Transporter 3 Inhibitors [MoA]

Package NDCNDC-11Package
66658-204-90666580204901 BOTTLE, GLASS in 1 CARTON (66658-204-90) / 90 mL in 1 BOTTLE, GLASS

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/00307f42-748d-4227-8c6f-ed5f0a89ae0a

Use it

Look up 66658-204 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/66658-204 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 66658-204. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.